Get my own profile
Public access
View all16 articles
1 article
available
not available
Based on funding mandates
Co-authors
- Klaus LiedlProfessor for Theoretical Chemistry, University of InnsbruckVerified email at uibk.ac.at
- Peter GedeckCollaborative Drug DiscoveryVerified email at collaborativedrug.com
- Julian FuchsBoehringer IngelheimVerified email at boehringer-ingelheim.com
- Anna VulpettiCADD, NovartisVerified email at novartis.com
- Tuomo KalliokoskiSenior Scientist at Orion PharmaVerified email at orionpharma.com
- M MeuwlyUniversity of BaselVerified email at unibas.ch
- Roland G. HuberBioinformatics Institute - Agency for Science, Technology and Research A*STAR, SingaporeVerified email at bii.a-star.edu.sg
- Paulette Greenidge FRSCScientific Executive DirectorVerified email at apheris.com
- Jean-Christophe MozziconacciSchrodingerVerified email at schrodinger.com
- Jérôme HertF. Hoffmann-La Roche Ltd.Verified email at chembio.info
- Tristan BereauProfessor of Physics, Heidelberg UniversityVerified email at thphys.uni-heidelberg.de
- Ulrike GrienkeUniversity of ViennaVerified email at univie.ac.at
- Judith RollingerUniversity of ViennaVerified email at univie.ac.at
- Michael SchauperlML Engineer, HotSpot TherapeuticsVerified email at hotspotthera.com
- Gerhard KlebeProfessor für Pharmazeutische Chemie, Philipps-UniversitätVerified email at mailer.uni-marburg.de
- Johannes KirchmairUniversity of ViennaVerified email at univie.ac.at
- Peter ErtlLeading Scientist at Ertl MolecularVerified email at peter-ertl.com
- Richard A. LewisNovartis, BaselVerified email at novartis.com
- Woody ShermanPsivant TherapeuticsVerified email at psivant.com
- Graeme RobbDirector, AstraZenecaVerified email at astrazeneca.com